Gossamer Bio (GOSS)
(Delayed Data from NSDQ)
$1.06 USD
+0.03 (2.91%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $1.05 -0.01 (-0.94%) 5:32 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Cash flow Statements
Fiscal Year End for Gossamer Bio, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -179.82 | -229.38 | -234.00 | -243.36 | -180.31 |
Depreciation/Amortization & Depletion | -3.74 | 4.19 | 12.24 | 8.22 | 0.96 |
Net Change from Assets/Liabilities | -11.86 | -1.74 | 4.35 | -0.24 | 12.23 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 36.26 | 39.90 | 28.52 | 59.02 | 22.28 |
Net Cash From Operating Activities | -159.16 | -187.03 | -188.89 | -176.36 | -144.83 |
Property & Equipment | 0.00 | -0.41 | -1.55 | -1.50 | -2.97 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -110.97 | -0.56 | -115.81 | 240.23 | -140.58 |
Other Investing Activities | 0.00 | -0.07 | -0.08 | -23.38 | -3.60 |
Net Cash from Investing Activities | -110.97 | -1.04 | -117.43 | 215.34 | -147.14 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 201.77 | 122.90 | 3.33 | 118.94 | 293.36 |
Issuance (Repayment) of Debt | -11.61 | -5.81 | 0.00 | 193.60 | 28.22 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 190.15 | 117.09 | 3.33 | 312.54 | 321.58 |
Effect of Exchange Rate Changes | 0.11 | -0.52 | -0.17 | 0.01 | 0.07 |
Net Change In Cash & Equivalents | -79.86 | -71.49 | -303.15 | 351.53 | 29.67 |
Cash at Beginning of Period | 111.97 | 183.47 | 486.62 | 135.09 | 105.42 |
Cash at End of Period | 32.11 | 111.97 | 183.47 | 486.62 | 135.09 |
Diluted Net EPS | -1.18 | -2.71 | -3.13 | -3.55 | -3.29 |
Fiscal Year End for Gossamer Bio, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -41.93 | -179.82 | -131.67 | -91.66 |
Depreciation/Amortization & Depletion | NA | -1.77 | -3.74 | -1.48 | -0.06 |
Net Change from Assets/Liabilities | NA | -13.93 | -11.86 | -13.59 | -14.42 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 5.33 | 36.26 | 21.00 | 14.89 |
Net Cash From Operating Activities | NA | -52.30 | -159.16 | -125.73 | -91.24 |
Property & Equipment | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 61.67 | -110.97 | -96.60 | 21.69 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | -0.03 |
Net Cash from Investing Activities | NA | 61.67 | -110.97 | -96.60 | 21.66 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.35 | 201.77 | 201.77 | 0.37 |
Issuance (Repayment) of Debt | NA | -2.90 | -11.61 | -8.71 | -5.81 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | -2.56 | 190.15 | 193.06 | -5.44 |
Effect of Exchange Rate Changes | NA | -0.06 | 0.11 | -0.08 | 0.05 |
Net Change In Cash & Equivalents | NA | 6.75 | -79.86 | -29.36 | -74.97 |
Cash at Beginning of Period | NA | 32.11 | 111.97 | 111.97 | 111.97 |
Cash at End of Period | NA | 38.86 | 32.11 | 82.61 | 37.00 |
Diluted Net EPS | NA | -0.19 | -0.21 | -0.21 | -0.45 |